327 related articles for article (PubMed ID: 29911367)
21. Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy.
Di Francia R; De Monaco A; Saggese M; Iaccarino G; Crisci S; Frigeri F; De Filippi R; Berretta M; Pinto A
Curr Cancer Drug Targets; 2018; 18(5):499-511. PubMed ID: 28183252
[TBL] [Abstract][Full Text] [Related]
22. Personalized Medicine: Pharmacogenomics and Drug Development.
Mirsadeghi S; Larijani B
Acta Med Iran; 2017 Mar; 55(3):150-165. PubMed ID: 28282716
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
24. Genetic databases in pharmacogenomics: the Frequency of Inherited Disorders Database (FINDbase).
Georgitsi M; Patrinos GP
Methods Mol Biol; 2013; 1015():321-36. PubMed ID: 23824866
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenetics of drug response in Parkinson's disease.
Džoljić E; Novaković I; Krajinovic M; Grbatinić I; Kostić V
Int J Neurosci; 2015; 125(9):635-44. PubMed ID: 25226559
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives.
Zhao J; Bian J; Zhao Y; Li Y; Liu B; Hao X; He S; Huang L
Paediatr Drugs; 2023 May; 25(3):301-319. PubMed ID: 36707496
[TBL] [Abstract][Full Text] [Related]
27. [Genetic biomarkers and personalized medicine: application in cardiovascular pharmacology].
Carrillo Norte JA
Rev Enferm; 2013 Jan; 36(1):41-50. PubMed ID: 23427736
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenomics and the future of toxicology testing.
Agrawal YP; Rennert H
Clin Lab Med; 2012 Sep; 32(3):509-23. PubMed ID: 22939305
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics/genomics and personalized medicine.
Sadée W; Dai Z
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
[TBL] [Abstract][Full Text] [Related]
30. Students' knowledge and views on pharmacogenomic education in the medical curriculum.
Agrawal M; Kirtania L; Jha A; Hishikar R
Indian J Pharmacol; 2021; 53(1):19-24. PubMed ID: 33975995
[TBL] [Abstract][Full Text] [Related]
31. Precision medicine for rheumatologists: lessons from the pharmacogenomics of azathioprine.
Daniel LL; Dickson AL; Chung CP
Clin Rheumatol; 2021 Jan; 40(1):65-73. PubMed ID: 32617765
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Pharmacogenomics in Personalized Medicine.
Singh DB
Adv Biochem Eng Biotechnol; 2020; 171():369-394. PubMed ID: 31485703
[TBL] [Abstract][Full Text] [Related]
33. Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective.
Lesko LJ; Woodcock J
Nat Rev Drug Discov; 2004 Sep; 3(9):763-9. PubMed ID: 15340386
[TBL] [Abstract][Full Text] [Related]
34. Vitamin Pharmacogenomics: New Insight into Individual Differences in Diseases and Drug Responses.
He HY; Liu MZ; Zhang YL; Zhang W
Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):94-100. PubMed ID: 28377107
[TBL] [Abstract][Full Text] [Related]
35. personalized medicine and pharmacogenomics: ethical and social challenges.
Lee SS
Per Med; 2005 Mar; 2(1):29-35. PubMed ID: 29793238
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics and pharmacogenomics in rheumatology.
Szekanecz Z; Meskó B; Poliska S; Váncsa A; Szamosi S; Végh E; Simkovics E; Laki J; Kurkó J; Besenyei T; Mikecz K; Glant TT; Nagy L
Immunol Res; 2013 Jul; 56(2-3):325-33. PubMed ID: 23564183
[TBL] [Abstract][Full Text] [Related]
37. Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.
Chaudhary R; Singh B; Kumar M; Gakhar SK; Saini AK; Parmar VS; Chhillar AK
Drug Metab Rev; 2015 Aug; 47(3):281-90. PubMed ID: 25996670
[TBL] [Abstract][Full Text] [Related]
38. [Personalized medicine for epilepsy based on the pharmacogenomic testing].
Yoshida S; Sugawara T; Nishio T; Kaneko S
Brain Nerve; 2011 Apr; 63(4):295-9. PubMed ID: 21441631
[TBL] [Abstract][Full Text] [Related]
39. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH
Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.
Terra SG; Johnson JA
Am J Cardiovasc Drugs; 2002; 2(5):287-96. PubMed ID: 14727958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
